The Hanover Insurance Group, Inc. filings document the regulatory record of a property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Its 8-K reports include results of operations and financial condition, earnings releases and unaudited financial supplements covering underwriting metrics, catastrophe losses, premiums, investment income, book value and related insurance performance measures.
The company’s proxy materials cover annual meeting procedures, shareholder voting matters, board governance and executive compensation disclosures. Other filings record capital-structure activity, including senior unsecured notes, note redemptions, registration-statement references and Form 25 records for the removal of a senior debenture class from exchange listing and registration.
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group President and CEO John C. Roche received 152.574 shares of common stock through restricted stock units granted under the company’s 2022 Long-Term Incentive Plan. These RSUs were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the original RSU grant date.
After this award, Roche directly holds 141,010.748 shares of Hanover common stock, and the filing notes an additional 14,454 shares held by his spouse. This transaction reflects routine equity-based compensation rather than an open-market purchase.
Salvatore Bryan J reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. Executive Vice President Salvatore J. Bryan received a grant of 30.677 restricted stock units as a dividend-related award in common stock. The units were granted under the company’s 2022 Long-Term Incentive Plan and tie to dividend equivalent rights on previously granted RSUs. These RSUs will vest on the third anniversary of the original underlying RSU grant date. Following this award, Bryan’s direct holdings total 29,069.276 shares of common stock.
Hanover Insurance Group, Inc. Schedule 13G/A: The Vanguard Group reports beneficial ownership of 0 shares of common stock, representing 0% of the class. The filing notes an internal realignment of Vanguard subsidiaries and states certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The Hanover Insurance Group is asking shareholders to vote at its May 12, 2026 annual meeting on three items: electing eight directors to one-year terms, an advisory approval of executive compensation, and ratification of PricewaterhouseCoopers as independent auditor.
The proxy highlights 2025 net income of $662.5 million, a combined ratio of 91.6%, net written premiums of $6,322.1 million up 3.9%, and stock repurchases of $130.1 million. Book value per share rose 27.4%, while the quarterly dividend increased 5.6% to $0.95, or $3.80 annually.
The Board reports that 10 of 11 directors are independent, the chair and CEO roles are separated, and the Board will be fully declassified in 2027. Executive pay is described as strongly performance-based, with 2025 short-term incentives funded at 140% of target and performance-based equity earned based on three-year relative total shareholder return and adjusted operating ROE.
Hanover Insurance Group director Jane D. Carlin reported an open-market sale of common stock. On February 27, 2026, she sold 1,200 shares at a weighted average price of $180.91 per share, with individual sale prices ranging from $180.79 to $181.02.
After this transaction, she directly owns 2,423 Hanover common shares. A footnote also notes an additional 2,306 shares held indirectly in a Rabbi Trust pursuant to deferral agreements, which are not included in the reported direct holdings.
Hanover Insurance Group Executive Vice President Dennis Francis Kerrigan reported a tax-related share disposition connected to vesting equity awards. On the vesting of previously granted restricted stock units, 1,751 shares of common stock were forfeited at $180.63 per share to cover withholding taxes, a non‑market transaction. After this withholding, Kerrigan directly holds about 11,968.723 Hanover common shares.
Hanover Insurance Group executive Jeffrey M. Farber reported a tax-related share disposition. On February 27, 2026, 5,507 shares of common stock were forfeited at $180.63 per share to cover withholding taxes triggered by the vesting of previously granted restricted stock units.
After this tax-withholding disposition, Farber directly holds 51,716.485 shares of Hanover Insurance Group common stock. The forfeited shares were not an open-market sale but an automatic share surrender under the terms of the equity award agreement.
HANOVER INSURANCE GROUP, INC. Executive Vice President Richard W. Lavey reported an administrative share disposition tied to equity compensation. On February 27, 2026, 3,220 shares of common stock at $180.63 per share were forfeited to cover withholding taxes upon the vesting of previously granted restricted stock units. After this tax-withholding disposition, he directly owned 34,382.74 common shares.
Hanover Insurance Group Executive Vice President Salvatore J. Bryan reported a Form 4 transaction involving 2,807 shares of common stock on February 27, 2026. These shares were forfeited to cover withholding taxes upon the vesting of previously granted restricted stock units at $180.63 per share. After this tax-withholding disposition, Bryan directly owned 29,038.599 shares of Hanover common stock.